Skip to main content
. 2021 Feb 25;36(1):693–706. doi: 10.1080/14756366.2021.1890726

Table 3.

2-Aminopyrimidines CDK9 inhibitors published by Changzhou Le Sun Pharmaceuticals.

  Inline graphic
Compound 11 (CDKI-73) 12 13
R Me H Me
X F F Cl
Ki (nM)      
 CDK9/T1 4 3 10.5
 CDK1/B 4 7 19
 CDK2/A 3 3 10
 CDK5/p35 0.5 1.5 1.5
 CDK6/D3 167 116 87.5
 CDK7/H 91 87 695
GI50 (nM)      
 Cytotoxicity* 30 225 75

CDK: cyclin-dependent kinase; GI50: half maximal inhibition of cell proliferation; Ki: inhibitory constant. *Average of two cell lines.